NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults

Active Not RecruitingPhase 4

Sponsor: Tor Biering-Sørensen

Conditions: RSV

Interventions: RSV prefusion F protein-based vaccine

Countries: Denmark, Spain

The purpose of this pragmatic randomized trial is to evaluate the vaccine effectiveness of bivalent RSV prefusion F vaccine (RSV vaccine) in adults. Participants will be randomized 1:1 to either RSV vaccine or no RSV vaccine.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria

* Age 18 years and above
* Informed consent form has been signed and dated

Exclusion Criteria:

* There are no specific exclusion criteria for this study

Locations (3)

Copenhagen, Denmark
Søborg, Denmark
Santiago de Compostela, A Coruña, Spain